Fidelis Capital Partners LLC Increases Position in CVS Health Co. (NYSE:CVS)

Fidelis Capital Partners LLC boosted its holdings in shares of CVS Health Co. (NYSE:CVS) by 55.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,729 shares of the pharmacy operator’s stock after acquiring an additional 6,357 shares during the period. Fidelis Capital Partners LLC’s holdings in CVS Health were worth $1,400,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of CVS. Live Oak Investment Partners purchased a new stake in shares of CVS Health in the 4th quarter valued at approximately $25,000. Atticus Wealth Management LLC grew its stake in shares of CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 219 shares during the period. Cornerstone Planning Group LLC grew its stake in shares of CVS Health by 111.5% in the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 243 shares during the period. PCA Investment Advisory Services Inc. purchased a new stake in shares of CVS Health in the 2nd quarter valued at approximately $37,000. Finally, ZRC Wealth Management LLC boosted its position in shares of CVS Health by 400.0% during the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after purchasing an additional 400 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insider Buying and Selling

In related news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now directly owns 39,765 shares in the company, valued at approximately $3,059,916.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.24% of the stock is owned by company insiders.

CVS Health Stock Up 1.2 %

Shares of CVS traded up $0.79 during midday trading on Thursday, reaching $69.39. The stock had a trading volume of 10,064,442 shares, compared to its average volume of 10,895,185. The company’s fifty day simple moving average is $75.53 and its two-hundred day simple moving average is $73.73. CVS Health Co. has a 1-year low of $64.41 and a 1-year high of $83.25. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The company has a market cap of $87.46 billion, a price-to-earnings ratio of 10.71, a PEG ratio of 0.91 and a beta of 0.52.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The firm had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. During the same period last year, the business earned $1.99 EPS. CVS Health’s revenue for the quarter was up 11.9% compared to the same quarter last year. Equities research analysts expect that CVS Health Co. will post 8.32 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be paid a dividend of $0.665 per share. The ex-dividend date is Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 3.83%. CVS Health’s dividend payout ratio is currently 41.18%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Royal Bank of Canada lowered their price objective on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research report on Thursday, February 8th. Leerink Partnrs reaffirmed an “outperform” rating on shares of CVS Health in a research report on Monday, February 26th. StockNews.com cut shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Wells Fargo & Company lowered their price objective on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a research report on Monday, April 8th. Finally, HSBC started coverage on shares of CVS Health in a report on Friday, December 22nd. They set a “buy” rating and a $94.00 target price on the stock. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $89.44.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.